TIFFANY SMITH: Open Payments
NPI 1336911171 · LAGRANGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 17 payments from 10 companies in 2025. Trend: 2023 $14 · 2024 $648 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Novo Nordisk Inc | 3 | $48 |
| PFIZER INC. | 3 | $44 |
| ABBVIE INC. | 2 | $40 |
| Verona Pharma, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: FARXIGA, Rybelsus, NURTEC ODT, VIBERZI, Ohtuvayre, Dexcom G6 Transmitter, Veozah, REXULTI.
Industry payments across IN — which companies pay providers there.
